2 completed, 2 recruiting, 1 withdrawn. 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Recruiting 2, Withdrawn 1 |
| Phase 2 | 5 | Completed 2, Recruiting 2, Withdrawn 1 |
Follow Bone Marrow Failure Syndromes: new trials by email Literature Review of Bone Marrow Failure Syndromes trials Research Report on Bone Marrow Failure Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes Dibotatug (DR-01) - Bone Marrow Failure Syndromes, Aplastic Anemias | Phase 1 / Phase 2 | Recruiting | Dren Bio | 60 | 2026-08-14 | 2026-11-04 |
| Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders RIC regimen, GVHD prophylaxis regimen - Severe Sickle Cell Disease, Bone Marrow Failure Syndromes | Phase 1 / Phase 2 | Recruiting | Washington University School of Medicine | 29 | 2017-03-20 | 2026-05-29 |
| Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation CD45RA-depleted peripheral blood mononuclear cells - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | Completed | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 30 | 2014-08-01 | 2016-04-22 |
| Nandrolone Decanoate in the Treatment of Telomeropathies Nandrolone Decanoate - Aplastic Anemia, Bone Marrow Failure Syndromes | Phase 1 / Phase 2 | Completed | University of Sao Paulo | 20 | 2014-02-01 | 2023-08-31 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies Enriched Hematopoetic Stem Cell Infusion - Anemia, Sickle Cell, Complex and Transfusion-dependent Hemoglobinopathies | Phase 1 / Phase 2 | Withdrawn | Talaris Therapeutics Inc. | 2011-05-01 | 2023-03-03 |
Bone Marrow Failure Disorders (5) · Anemia, Aplastic (2) · Anemia, Sickle Cell (2) · Anemia, Diamond-Blackfan (1) · Graft vs Host Disease (1) · Hematologic Diseases (1) · Hemoglobinopathies (1) · Idiopathic Pulmonary Fibrosis (1) · Immune Deficiency Disease (1) · Immune System Diseases (1) · Leukemia, Myeloid, Acute (1) · Leukocyte Disorders (1) · Metabolic Diseases (1) · Opportunistic Infections (1) · Pancytopenia (1)
Bone Marrow Diseases (5) · Hemic and Lymphatic Diseases (5) · Anemia (4) · Hematologic Diseases (4) · Anemia, Hemolytic (2) · Anemia, Hemolytic, Congenital (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Anemia, Aplastic (1) · Anemia, Hypoplastic, Congenital (1) · Congenital Bone Marrow Failure Syndromes (1) · Cytopenia (1) · Disease Attributes (1) · Hemoglobinopathies (1) · Immune System Diseases (1)
Dren Bio (1) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · Talaris Therapeutics Inc. (1) · University of Sao Paulo (1) · Washington University School of Medicine (1)
United States (3) · Brazil (1) · Russia (1)
Ana Beatriz Hortense, MD (1) · Michael Maschan, MD (1) · Rodrigo T Calado, MD, PhD (1) · Shalini Shenoy, MD (1) · Suzanne T Ildstad, MD (1) · Wan-Jen Hong, MD (1)